TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Genor Biopharma Holdings Limited ( (HK:6998) ) has shared an announcement.
Genor Biopharma Holdings Limited has announced its upcoming Annual General Meeting scheduled for June 26, 2025, in Shanghai, China. Key agenda items include the adoption of the company’s audited financial statements for 2024, re-election of directors, and re-appointment of Ernst & Young as auditors. Additionally, resolutions will be considered regarding the repurchase of shares and the issuance of additional shares, reflecting the company’s strategic focus on enhancing shareholder value and operational flexibility.
More about Genor Biopharma Holdings Limited
Genor Biopharma Holdings Limited is a company incorporated in the Cayman Islands, primarily involved in the biopharmaceutical industry. The company focuses on the development and commercialization of biologics for the treatment of cancer and other diseases.
YTD Price Performance: 47.98%
Average Trading Volume: 724,486
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.33B
See more insights into 6998 stock on TipRanks’ Stock Analysis page.